reference/36412388

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/36412388

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
issn	2666-3791
issueIdentifier	12
pageRange	101302-
publicationName	Cell reports. Medicine
startingPage	101302
bibliographicCitation	Duan J, Zhang Y, Chen R, Liang L, Huo Y, Lu S, Zhao J, Hu C, Sun Y, Yang K, Chen M, Yu Y, Ying J, Huang R, Ma X, Leaw S, Bai F, Shen Z, Cai S, Gao D, Wang J, Wang Z. Tumor-immune microenvironment and NRF2 associate with clinical efficacy of PD-1 blockade combined with chemotherapy in lung squamous cell carcinoma. Cell Reports Medicine. 2023 Dec;4(12):101302. doi: 10.1016/j.xcrm.2023.101302.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6d3dfc896921c4c6a3928ec0a399011d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_41032535f40d3ff71564823225d2a690 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a1c96e32761d17eb69ff426a17c8b85f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3aac5fb01813815ba60c6a3ff3a84a66 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bc452029d9dab47407dde069e36352f8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cb6a37beb991a3cfa99c228de95b6ce0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_98b0de0cf6408e365af368a48806b435 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_efaa34a12cb58d751cbbdb91af94b43f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_706ecacfc0c312b92271d55c3335b5ee http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c6aa13b2966924098b041f30e95d160d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f06aea4929e0b9bda2cbb5e2270451f6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f048fb504b1cf46763b079bb298d56fe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_98860429d07c57113207101a05ce8b7b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4e76fdae02f28aa773f2bd3a10ab0ffa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6698a30741ef0420f6d8cc0fa82270a4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_19b339dd9108dabacdef90405f26a978 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f7d561b0aa1ccdcbba274be336c30389 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7722-4956 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4b265671698e4f80cb87ffb1c216e4d4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_43c5a7cb0e34024f43faecee281a9201 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5920a136af9ec675c36cf76ba8163a33 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9137fe389d3788dfc8786b5f58f9a09a
date	2023-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1016/j.xcrm.2023.101302 https://pubmed.ncbi.nlm.nih.gov/PMC10772345 https://pubmed.ncbi.nlm.nih.gov/38052215
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/49562 https://portal.issn.org/resource/ISSN/2666-3791
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Tumor-immune microenvironment and NRF2 associate with clinical efficacy of PD-1 blockade combined with chemotherapy in lung squamous cell carcinoma
discusses	http://id.nlm.nih.gov/mesh/M0237441 http://id.nlm.nih.gov/mesh/M0556121 http://id.nlm.nih.gov/mesh/M0022149 http://id.nlm.nih.gov/mesh/M0479977 http://id.nlm.nih.gov/mesh/M0555734
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D002294Q000188 http://id.nlm.nih.gov/mesh/D002294Q000235 http://id.nlm.nih.gov/mesh/D002289Q000188 http://id.nlm.nih.gov/mesh/D002294Q000473 http://id.nlm.nih.gov/mesh/D008175Q000188 http://id.nlm.nih.gov/mesh/D008175Q000235 http://id.nlm.nih.gov/mesh/D008175Q000473
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D061026 http://id.nlm.nih.gov/mesh/D051267Q000235 http://id.nlm.nih.gov/mesh/D014408Q000235 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D009154 http://id.nlm.nih.gov/mesh/D060890Q000235 http://id.nlm.nih.gov/mesh/D059016Q000235 http://id.nlm.nih.gov/mesh/D008168Q000473

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4780

Total number of triples: 61.